Desne Francois

Cadre supérieur

Insider activity · 24 months2 buys1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 2 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 1 saleJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (2 ops.)

—

▼ Sales (1 ops.)

€121k

Latest filing published 04 Jun 2026 for BEKAERT, €121k. Read the official filing

Filing timeline

BuySale

Desne Francois

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Closed purchases

Market purchases

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

BEKAERT 2 purchases · last 20 Mar 2026

Desne Francois: trading record in brief

Desne Francois, listed as senior executive, appears in our data through filings on Bekaert shares, published by FSMA. Over a trading history stretching from 4 March 2026 to 3 June 2026, the count stands at 3 filings.

Market trades split into 2 purchases and 1 sale (€121k). No amount is published for 2 filings, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

Most recently, on 4 June 2026, the filings show an open-market sale worth €121k in Bekaert. The latest purchase dates back some time: it was published 212 days ago, on 20 March 2026. Typically, a trade is published a median of 1 day after it takes place. The regulation allows three business days to notify a trade (MAR article 19). These figures are compiled from regulatory filings published by FSMA. They describe what insiders did and are not a recommendation.